We articulate on a long-term leverage ratio 2.5x to 3.5x, EBITDA growth of 4% to 6%, a 10% to 15% TSR growth, we’ve established annual dividend. We’re buying back our shares because it’s a compelling opportunity. When you consider where we trade versus our peer group, and you contrast that with our results. This is an exciting time. So, this is a great franchise that will be focused on how we take it to the next level and our targeted investments around organic growth, are absolutely paying dividends that as you can see in the investor deck in terms of how we’ve been trending versus our peer group since 2019, the story around Berry and Berry’s growth, it’s addressed in that slide. We’re in-line with our peer group right now and you couple that with our scale, our geographic footprint, our leadership position in sustainability, we’re in a great spot, Gabe.
I’m proud to be part of this team. I’m proud of what the team is doing and whoever has the opportunity to take this seat is in a great spot to take the company to the next level. So, we’re in a great place.
Gabe Hajde: Thank you very much.
Operator: One moment for our next question. will come from the line of Josh Spector with UBS. Your line is open.
Josh Spector: Hey guys. Thanks for squeezing me in and I echo my congrats, Tom. So, I wanted to ask on Consumer International. If I look at, when you first bought that business, first 12 months, it did about 650 million in EBITDA, last 12 months it’s done about 650 million in EBITDA. Consensus is forecasting that same level for this year. I mean I understand FX probably slightly negative over two years, but you have synergies rolling through, I guess, how much is that business or is that business under earning in your view? And can you help us think about what the normal level of earnings is for that business today? Thank you.
Mark Miles: Yes, it’s Mark. So, yes, I didn’t exactly follow on your numbers, but I would say the other thing that you got to consider is divestitures. The divestitures that Tom mentioned were in that business. It has grown its EBITDA, and we think it will continue to be able to deliver that. We’ve got a lot of great opportunities. Tom mentioned some of the investments that we’re making in that business, health care, dispensing solutions, pharmaceutical devices continue to be areas of opportunity. And we’ve also got the growth dynamics in India, China, et cetera. So, we think that business can €“ we’re doing the right things. Pete is doing a great job, and we’re opportunistic about the future of that business.
Josh Spector: Okay. Thank you.
Operator: I’m showing no further questions in the queue at this time. I would now like to turn the call back over to management for any closing remarks.
Tom Salmon: Thanks, everybody, for your time and attention today. We appreciate your interest in Berry. We look forward to seeing you all and hearing from you on the next call. Thank you.
Operator: Thank you all for participating in today’s call. This concludes today’s program. You may now disconnect.
